Dai-ichi Life Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-888,050
Closed -$28.5M 344
2016
Q3
$28.5M Sell
888,050
-2,909
-0.3% -$97.3K 0.87% 20
2016
Q2
$29.8M Sell
890,959
-5,507
-0.6% -$176K 0.9% 14
2016
Q1
$25.2M Buy
896,466
+78,925
+10% +$2.25M 0.76% 20
2015
Q4
$25M Sell
817,541
-43,965
-5% -$1.38M 0.78% 19
2015
Q3
$25.7M Sell
861,506
-9,175
-1% -$294K 0.8% 17
2015
Q2
$27.7M Sell
870,681
-34,362
-4% -$1.12M 0.83% 11
2015
Q1
$29.9M Sell
905,043
-94,967
-9% -$3.02M 0.84% 12
2014
Q4
$29.6M Sell
1,000,010
-40,696
-4% -$1.17M 0.85% 14
2014
Q3
$29.2M Buy
1,040,706
+7,312
+0.7% +$205K 0.87% 14
2014
Q2
$29.1M Sell
1,033,394
-84,833
-8% -$2.42M 0.91% 12
2014
Q1
$34.1M Sell
1,118,227
-46,848
-4% -$1.4M 1.08% 11
2013
Q4
$33.9M Sell
1,165,075
-4,004
-0.3% -$117K 1.04% 12
2013
Q3
$31.8M Sell
1,169,079
-115,789
-9% -$3.15M 1.12% 11
2013
Q2
$34.1M Buy
+1,284,868
New +$35.5M 1.2% 13

Other funds holding PFE

Dai-ichi Life Holdings's PFE Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Pfizer (PFE) in Q4 2016, closing a stake of 888,050 shares — an estimated $28.5M sold.

Dai-ichi Life Holdings first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $34.1M in Q2 2013. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 888,050 Pfizer shares in Q4 2016, an estimated $28.5M.
  • Dai-ichi Life Holdings first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Pfizer position peaked at $34.1M in Q2 2013.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.